Open Access

Using empagliflozin for HFpEF treatment - what does this look like in practice?

Topic: Chronic Heart Failure
Sponsored by Boehringer Ingelheim and Eli Lilly and Company

Congress Presentation

About the speaker

Doctor Shelley Zieroth

University of Manitoba, Winnipeg (Canada)
46 presentations

3 more presentations in this session

Welcome and introduction.

Speaker: Professor A. Stewart Coats (Coventry, GB)


What is the evidence for empagliflozin in HF?

Speaker: Professor J. Butler (Dallas, US)


Panel discussion and close.

Speaker: Professor A. Stewart Coats (Coventry, GB)


Access the full session

A new era for HFpEF – Exploring the role of empagliflozin in practice

Speakers: Doctor S. Zieroth, Professor A. Stewart Coats, Professor J. Butler, Professor A. Stewart Coats

About the event


Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb